Randomized Trialhigh evidence
Human induced pluripotent stem cell-derived cardiomyocytes improve recovery from myocardial infarction in non-human primates.
Stem cell research & therapy·October 27, 2025·PMID 41146358
Why it mattersThis study provides preclinical evidence in a large animal model that hiPSC-CM therapy can remuscularize infarcted myocardium and improve function, supporting further development toward human trials.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled